SHA:603538 Revenue

Ningbo Menovo Pharmaceutical had revenue of 276.48M CNY in the quarter ending March 31, 2025, with 5.22% growth. This brings the company's revenue in the last twelve months to 1.39B, up 12.46% year-over-year. In the year 2024, Ningbo Menovo Pharmaceutical had annual revenue of 1.37B with 12.85% growth.

Revenue (ttm)

1.39B

Revenue Growth

+12.46%

P/S Ratio

2.93

Revenue / Employee

560.91K

Employees

2,472

Market Cap

4.06B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.37B	156.36M	12.85%
Dec 31, 2023	1.22B	-240.48M	-16.51%
Dec 31, 2022	1.46B	198.83M	15.80%
Dec 31, 2021	1.26B	64.77M	5.43%
Dec 31, 2020	1.19B	13.17M	1.12%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Sichuan Biokin Pharmaceutical	5.82B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings